Projects per year
Fingerprint
Dive into the research topics where John Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma
Park, J., Sabanathan, D., Xia, C., Kim, S. & Chapman, N.
3/08/21 → 29/07/26
Project: Research
-
ACT16849: A Phase 2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR-707) combined with other anticancer therapies for the treatment of participants with lung cancer or pleural mesothelioma
Park, J., Chapman, N. & Tan, P.
13/05/21 → 15/04/26
Project: Research
-
CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors
Park, J., Sabanathan, D. & Chapman, N.
30/10/20 → 24/09/25
Project: Research
-
EFC15935: A randomized, multicentre, double-blind phase 3 study of SAR439859 plus palbociclib versus letrozole plus palbociclib for the treatment of patients with ER (+), HER2 (-) breast cancer who have not received prior systemic anti-cancer treatment for advanced disease
Sabanathan, D., Park, J. & Chapman, N.
30/09/20 → 30/09/25
Project: Research
-
Circulating tumor DNA reflects uveal melanoma responses to protein kinase C inhibition
Park, J. J., Diefenbach, R. J., Byrne, N., Long, G. V., Scolyer, R. A., Gray, E. S., Carlino, M. S. & Rizos, H., 1 Apr 2021, In: Cancers. 13, 7, p. 1-14 14 p., 1740.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)3 Downloads (Pure) -
The impact of nonsteroidal anti-inflammatory drugs, beta blockers, and metformin on the efficacy of anti-PD-1 therapy in advanced melanoma
Wang, D. Y., McQuade, J. L., Rai, R. R., Park, J. J., Zhao, S., Ye, F., Beckermann, K. E., Rubinstein, S. M., Johnpulle, R., Long, G. V., Carlino, M. S., Menzies, A. M., Davies, M. A. & Johnson, D. B., 1 Mar 2020, In: Oncologist. 25, 3, p. e602-e605 4 p.Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus) -
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Johansson, P. A., Brooks, K., Newell, F., Palmer, J. M., Wilmott, J. S., Pritchard, A. L., Broit, N., Wood, S., Carlino, M. S., Leonard, C., Koufariotis, L. T., Nathan, V., Beasley, A. B., Howlie, M., Dawson, R., Rizos, H., Schmidt, C. W., Long, G. V., Hamilton, H., Kiilgaard, J. F. & 15 others, , 15 May 2020, In: Nature Communications. 11, 1, p. 1-8 8 p., 2408.Research output: Contribution to journal › Article › peer-review
Open AccessFile26 Citations (Scopus)2 Downloads (Pure) -
Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma
Hwang, S. J. E., Park, J. J. W., Wakade, D., Chou, S., Byth, K. & Fernández-Peñas, P., Apr 2019, In: Melanoma Research. 29, 2, p. 172-177 6 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma
da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In: Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.Research output: Contribution to journal › Article › peer-review
25 Citations (Scopus)